scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.34), $0.05 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $16 million versus the consensus estimate of $15.41 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.